This inventor holds 1 USPTO granted patent. Top assignee: Xoma Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Hélène Gazzano-Santoro: Innovator in Biologically Active Proteins
Introduction
Hélène Gazzano-Santoro is a notable inventor based in San Bruno, California. He has made significant contributions to the field of biotechnology, particularly in the development of novel biologically active proteins. His work has implications for various medical applications, especially in immunology.
Latest Patents
Hélène holds a patent for "Lipopolysaccharide binding protein derivatives." This patent discloses innovative lipopolysaccharide binding protein (LBP) derivatives, including hybrid proteins that can bind to and neutralize lipopolysaccharide (LPS). These derivatives are characterized by their lack of CD14-mediated immunostimulatory properties, setting them apart from traditional holo-LBP.
Career Highlights
Hélène is currently associated with Xoma Corporation, a company known for its focus on therapeutic antibodies and innovative biopharmaceuticals. His work at Xoma has allowed him to explore and develop groundbreaking solutions in the field of immunology.
Collaborations
Hélène has collaborated with several professionals in his field, including Georgia Theofan and Patrick W. Trown. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Hélène Gazzano-Santoro's contributions to biotechnology, particularly through his patented innovations, highlight his role as a key figure in the development of novel therapeutic solutions. His work continues to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile